AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
AstraZeneca's Treatment for Nerve Damage Advocated for EU Approval
October 21, 2024 07:47 PM AEDT| By Team Kalkine MediaHighlights,AstraZeneca's Wainzua nerve damage treatment has received a recommendation for approval from the European Medicines Agency (EMA).,The treatment, known as eplontersen, is already approved in the US for adults with hereditary transthyretin-m...
Wainzua Recommended for EU Approval: A Potential Breakthrough for hATTR-PN Treatment
October 21, 2024 06:45 PM AEDT| By Team Kalkine MediaHighlights:,Wainzua recommended for EU approval as the first self-administered treatment for hereditary transthyretin-mediated amyloidosis.,Phase III NEURO-TTRansform trial shows significant improvements in neuropathy impairment and quality of life.,...
Merck's RSV Treatment Shows Promising Results in Latest Clinical Trial
October 19, 2024 04:38 AM AEDT| By Team Kalkine MediaHighlights:,Positive Clinical Trial Results:,Merck's clesrovimab reduces RSV-related hospitalizations by over 84% in a mid-to-late-stage trial.,No Major Side Effects:,The treatment showed no significant adverse effects while reducing respiratory infe...
Despite a 28% Decline, Inspiration Healthcare Group plc (LON:IHC) Shows Positive Screening Results, Though Risks May Be Present
October 18, 2024 07:52 PM AEDT| By Team Kalkine MediaHighlights:,Inspiration Healthcare Group plc shares have declined by 28% in the past month, contributing to a significant 55% loss over the last twelve months.,The company's price-to-sales (P/S) ratio stands at 0.4x, considerably lower than the indus...
Oncimmune's Recapitalisation Efforts Lead to a 7% Gain in Share Price
October 18, 2024 07:37 PM AEDT| By Team Kalkine MediaHighlights:,Oncimmune Holdings PLC has experienced a 7% increase in share price following a successful fundraising initiative and debt restructuring.,The company is set to raise a minimum of £2 million through a share placing, board subscription, and...
Weight Loss Drugs Like Ozempic Could Curb Alcohol, Opioid Addiction
October 18, 2024 12:35 AM AEDT| By Team Kalkine MediaHighlights:,Study Findings,: GLP-1 drugs like Ozempic were linked to a 40% lower rate of opioid overdoses and a 50% reduction in alcohol intoxication among users.,Substance Abuse Impact,: The study tracked over 1.3 million individuals with alcohol an...
A stock decline of 11% this week has led to a 78% loss for shareholders in BATM Advanced Communications
October 17, 2024 06:45 PM AEDT| By Team Kalkine MediaHighlights:,BATM Advanced Communications Ltd. has seen a dramatic 78% decline in share price over the past three years, raising concerns among shareholders.,The company's earnings per share (EPS) has fallen significantly, contributing to the drop in...
Avacta Group Expands Oncology Pipeline with Two Novel Preclinical Assets: AVA6103 and AVA7100
October 17, 2024 06:38 PM AEDT| By Team Kalkine MediaHighlights,Avacta has added two new preclinical oncology assets, AVA6103 and AVA7100, to its pipeline, utilizing its pre|CISION® technology.,AVA6103 targets tumors with exatecan, a potent antitumor drug, while reducing its systemic toxicities.,AVA710...
Feedback PLC Secures Key NHS Funding for Bleepa Platform, Shares Surge Over 55%
October 16, 2024 10:01 PM AEDT| By Team Kalkine MediaHighlights:,NHS Funding Boost,: Feedback’s Bleepa platform becomes eligible for reimbursement under the NHS Elective Recovery Fund.,Strategic Partnership,: Partnership with Moorhouse Consulting to accelerate Bleepa’s implementation across NHS organis...
Image Scan Secures £3 Million Deal with NP Aerospace for Portable X-ray Systems
October 16, 2024 09:57 PM AEDT| By Team Kalkine MediaHighlights:,Major Contract Secured,: Image Scan Holdings signed a £3 million deal with NP Aerospace for its portable X-ray systems.,Long-term Revenue Impact,: The contract is expected to positively impact revenues in 2025 and 2026.,Share Price Surge,...
Graft Polymer Partners with University of Nottingham to Research New Mental Health Therapeutics
October 15, 2024 06:58 PM AEDT| By Team Kalkine MediaKey Points:,Graft Polymer and Awakn Life Sciences have partnered with the University of Nottingham to study the potential of an aminoindane new chemical entity (NCE) in enhancing social cognition for trauma-related disorders.,Led by Dr. Madeleine Kin...
IQ-AI is nearing an important milestone in its cancer treatment initiatives
October 15, 2024 06:50 PM AEDT| By Team Kalkine MediaHighlights:,IQ-AI Ltd is nearing completion of its Phase I clinical trial for the IB003 cancer treatment, with only two patients remaining to enroll.,Preparations are underway for a meeting with the US Food and Drug Administration (FDA) to discuss th...
Avacta Group Strengthens Leadership with Oncology Expert Michelle Morrow
October 15, 2024 06:13 PM AEDT| By Team Kalkine MediaKey Points,:,Dr. Michelle Morrow, an experienced oncology expert, has been appointed as Chief Scientific Officer at Avacta Group.,She brings nearly 20 years of experience in oncology therapeutics and antibody research, including leadership roles at i...
_10_15_2024_12_58_09_224155.jpg)
Lundbeck Acquires Longboard Pharmaceuticals in $2.6bn Deal to Bolster Neurological Pipeline
October 15, 2024 10:00 AM AEDT| By Team Kalkine MediaHighlights:,Strategic Acquisition,: Lundbeck will acquire Longboard Pharmaceuticals for $2.6 billion, strengthening its portfolio of treatments for neurological diseases.,Promising Drug Addition,: Longboard's lead asset, bexicaserin, has shown promis...
Oxford BioDynamics Faces Urgent Need for New Funding Amid Share Plunge
October 14, 2024 10:13 PM AEDT| By Team Kalkine MediaHighlights:,New Funding Needed,: Oxford BioDynamics announced that it requires additional funding by Q1 2025 to maintain operations.,Cost-Cutting Initiatives,: Senior staff will receive 25% of their pay in shares as part of efforts to conserve cash.,...
Mendell Helium Sells Plant-Based Health and Wellness Business to Orsus Therapeutics
October 14, 2024 10:13 PM AEDT| By Team Kalkine MediaHighlights:,Strategic Sale,: Mendell Helium sells its plant-based health and wellness business to Orsus Therapeutics, retaining a 28% stake.,Helium Focus,: Mendell shifts its business direction towards helium assets in North America.,Future Growth,:...
Positive Outcomes in Phase III Nasal Polyps Study Highlighted by GSK
October 14, 2024 06:24 PM AEDT| By Team Kalkine MediaHighlights:,GSK PLC reports positive results from two phase III clinical trials (ANCHOR-1 and ANCHOR-2) for its treatment depemokimab targeting chronic rhinosinusitis with nasal polyps (CRSwNP).,Patients treated with depemokimab demonstrated signific...
Verici Dx Postpones ‘Tutivia’ Revenue as Medicare Approval Drags On
October 11, 2024 11:01 PM AEDT| By Team Kalkine MediaHighlights:,CMS Coverage Delay,: Verici Dx’s Tutivia test faces a delay in Medicare approval, pushing revenue recognition to 2025.,Financial Stability,: Verici Dx maintains a $6.1 million cash balance and a disciplined cost-control approach, aligning...
SkinBioTherapeutics Acquires Bio-Tech Solutions Ltd for £1.25 Million
October 11, 2024 07:27 PM AEDT| By Team Kalkine MediaHighlights,SkinBioTherapeutics has acquired Bio-Tech Solutions Ltd for £1.25 million.,The deal will be financed through a combination of a £950,000 loan from a shareholder, a subscription for new shares raising £250,000, and the use of the company's...
ProBiotix Health Enters New Partnership with Mexico-Based Raff
October 10, 2024 09:01 PM AEDT| By Team Kalkine MediaKey Points:,Strategic Partnership,: ProBiotix teams up with Raff, a key player in the Mexican dairy and nutraceutical sectors.,Market Potential,: Mexico’s high cardiovascular disease rates present a lucrative opportunity for health-focused probiotic...
AI on the Rise: A Look at Top AI Companies and Their Stocks